共 242 条
[41]
Fau-Witte L(2008)Inhibitory anti-FLT3 antibodies are capable of mediating antibody-dependent cell-mediated cytotoxicity and reducing engraftment of acute myelogenous leukemia blasts in nonobese diabetic/severe combined immunodeficient mice Cancer Res 68 9280-undefined
[42]
Nakao M(2018)Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody J Exp Clin Cancer Res 37 20-undefined
[43]
Yokota S(2016)Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate Molecules 21 1375-undefined
[44]
Iwai T(2010)Fate of antibody-drug conjugates in cancer cells Can Res 70 2528-undefined
[45]
Kaneko H(2008)Novel natural product- and privileged scaffold-based tubulin inhibitors targeting the colchicine binding site Biologics 2 717-undefined
[46]
Horiike S(2019)Antibody-maytansinoid conjugates designed to bypass multidrug resistance Proc Natl Acad Sci U S A 116 3100-undefined
[47]
Kashima K(2005)Denileukin diftitox for the treatment of cutaneous T-cell lymphoma Clin Cancer Res 10 8293-undefined
[48]
Hamann PR(1998)Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti-PD-1 in melanoma J Biol Chem 273 17626-undefined
[49]
Hinman LM(2014)Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window Can Res 74 2569-undefined
[50]
Hollander I(undefined)Structure-function analysis of FLT3 Ligand-FLT3 receptor interactions using a rapid functional screen undefined undefined undefined-undefined